title: Spontaneous in vitro production of rheumatoid factor during infectious exacerbations of cystic fibrosis: correlation with circulating immune complex levels.
abstract: Rheumatoid factor (RF) production has been demonstrated during infections, including infectious exacerbations of cystic fibrosis (CF). The aim of this study was to evaluate the relationship of RF production to infection, and examine the mechanisms involved. Serial peripheral blood mononuclear cell (PBMC) cultures with measurement of spontaneous production of IgM RF, IgA RF, total IgM and IgA, and measurement of serum levels of immune complexes were carried out during exacerbations of CF. The percentage of B cells expressing CD5 was examined in a second cohort of acutely infected CF patients, and related to IgM RF production. IgM RF production was significantly elevated during acute infection compared with convalescence (P < 0.05), stable CF subjects (P < 0.005) and normal controls (P < 0.05). IgM RF production did not correlate with total IgM production in the majority of patients, but was closely related to circulating immune complex levels in 8/10 subjects. IgA RF production did not increase significantly during infection, and did not correlate with total IgA or IgM RF production, or with circulating immune complex levels. CD5+ B cells were not increased in the CF group, and the percentage of CD5+ B cells did not correlate with IgM RF synthesis. These observations suggest that RF production during infection is specifically induced, possibly by immune complex autoimmunization, and is not simply the result of polyclonal B cell activation. Different patterns of IgM RF and IgA RF synthesis suggest different mechanisms of induction.
authors.affiliation: Department of Respiratory Medicine (Adult Cystic Fibrosis Unit, University College, Dublin, Ireland.
authors.forename: M T
authors.initials: MT
authors.lastname: Keogan
authors.forename: M
authors.initials: M
authors.lastname: Callaghan
authors.forename: G
authors.initials: G
authors.lastname: Yanni
authors.forename: D
authors.initials: D
authors.lastname: Mulherin
authors.forename: C
authors.initials: C
authors.lastname: Feighery
authors.forename: D L
authors.initials: DL
authors.lastname: Brown
authors.forename: M X
authors.initials: MX
authors.lastname: Fitzgerald
authors.forename: B
authors.initials: B
authors.lastname: Bresnihan
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000936:Antigen-Antibody Complex / Q000097:blood*; D015703:Antigens, CD / Q000276:immunology; D001323:Autoantibodies / Q000276:immunology; D001402:B-Lymphocytes / Q000276:immunology; D018956:CD5 Antigens; D002478:Cells, Cultured; D003550:Cystic Fibrosis / Q000097:blood / Q000276:immunology*; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000276:immunology; D007075:Immunoglobulin M / Q000096:biosynthesis; D008297:Male; D011552:Pseudomonas Infections / Q000276:immunology*; D012217:Rheumatoid Factor / Q000096:biosynthesis*; D013203:Staphylococcal Infections / Q000276:immunology*
chemical_list: D000936:Antigen-Antibody Complex; D015703:Antigens, CD; D001323:Autoantibodies; D018956:CD5 Antigens; D007070:Immunoglobulin A; D007075:Immunoglobulin M; D012217:Rheumatoid Factor